GSK Awaits FIPB Decision To Allow 75% Stake In GSK India
This article was originally published in PharmAsia News
Executive Summary
GlaxoSmithKline reportedly will be watching closely the Jan. 10 meeting of India's Foreign Investment Promotion Board to see if it allows the U.K.-based company to acquire 75% of its India subsidiary.